Pharmaids Pharmaceuticals Ltd (PHARMAID) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Pharmaids Pharmaceuticals Ltd reported sales of ₹4.12 Cr, operating profit of ₹-0.75 Cr (OPM -18.2%) and net profit of ₹1.88 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
PHARMAID quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 5.24 4.71 4.77 6.66 8.61 5.43 7.18 4.12 Expenses 7.65 7.6 8.67 12.03 13.93 7.94 7.52 4.87 Operating Profit -2.41 -2.89 -3.9 -5.37 -5.32 -2.51 -0.34 -0.75 OPM -45.99% -61.36% -81.76% -80.63% -61.79% -46.22% -4.74% -18.2% Other Income 0.08 0 0.13 0.04 3.03 -0.32 0.01 4.25 Interest 0.33 0.48 1.01 1.2 0.93 0.72 0.65 0.6 Depreciation 0.61 0.64 0.62 0.61 0.47 0.48 0.48 0.49 Profit before tax -3.27 -4.01 -5.4 -7.14 -3.69 -4.03 -1.46 2.41 Tax -30.58% -24.94% -11.11% -26.05% -30.62% -34.24% -25.34% 22.41% Net Profit -2.27 -3.01 -4.8 -5.27 -2.57 -2.65 -1.09 1.88 EPS in Rs -0.55 -0.55 -1.12 -1.39 -0.71 -0.7 -0.51 0.63
PHARMAID profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 3.94 0 15.11 19.45 27.88 25.34 Expenses 3.81 9.89 27.46 32.2 41.39 34.26 Operating Profit 0.13 -9.89 -12.35 -12.75 -13.51 -8.92 OPM 3.3% - -81.73% -65.55% -48.46% -35.2% Other Income 0.02 0 0.03 0.01 2.75 6.97 Interest 0 0 1.58 2.1 3.52 2.9 Depreciation 0.01 0.02 1.72 2.44 2.03 1.92 Profit before tax 0.14 -9.91 -15.62 -17.28 -16.31 -6.77 Tax 0% -23.71% -24.2% -21.88% -29% - Net Profit 0.15 -7.56 -11.85 -13.51 -11.57 -4.43 EPS in Rs 0.15 -3.52 -2.26 -3.06 -3.32 -1.29 Dividend Payout 0% 0% 0% 0% 0% -
PHARMAID balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 21.44 35.27 35.27 35 35.27 Reserves 1.02 36.78 24.05 17 12.39 Borrowings 0 8.53 38.98 20 23.39 Other Liabilities 2.13 10.75 21.54 26 16.21 Total Liabilities 24.59 91.33 119.84 98 87.26 Fixed Assets 0.11 63.42 76.61 55 53.94 CWIP 2 7 4.53 3 6.1 Investments 3.31 0 0 0 0 Other Assets 19.17 20.91 38.7 41 27.22 Total Assets 24.59 91.33 119.84 98 87.26
PHARMAID cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity -0.26 -4.02 -10.62 -15.11 -4.06 Cash from Investing Activity 0.47 -4.94 -74.99 -12.22 23.34 Cash from Financing Activity 0 21.31 77.66 23.36 -19.97 Net Cash Flow 0.21 12.35 -7.95 -3.98 -0.69 Free Cash Flow -0.26 -5.69 -33.33 -27.37 11.05 CFO/OP -200% 41% 86% 118% 30%
PHARMAID ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 124.14 - 64.74 58.74 44.9 Inventory Days 90.99 0 111.61 346.51 8.73 Days Payable 236.18 - 159.18 464.29 59.17 Cash Conversion Cycle -21.05 - 17.17 -59.04 -5.54 Working Capital Days -17.6 - -68.6 -160.26 -172.16 ROCE - -63.67% -25.99% -17.43% -18.48%